UROAMPLITUDE Trademark Information

Trademark by Convergent Genomics, Inc.

Medical testing for diagnostic or treatment purposes in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; providing cancer screening services

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: UROAMPLITUDE
Status/Status Date:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
9/13/2021
Estimated Response Deadline: 3/13/2022
Serial Number: 90523219
Filing Date: 2/10/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Medical testing for diagnostic or treatment purposes in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; providing cancer screening services
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Convergent Genomics, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
9/13/2021
Correspondent Search:
SHEILA FOX MORRISON is a correspondent of UROAMPLITUDE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on